Dose range of medication included in the network meta-analysis for adults, according to the FDA whenever possible (as retrieved in https://dailymed.nlm.nih.gov/dailymed/ or http://www.accessdata.fda.gov/; other sources: http://integratedcare-nw.org/docs/PCPtraining/AdultADHDSummary-Recommendations.pdf; Arnsten et al72)
| Drug | Min. daily dose | Max. daily dose |
|---|---|---|
| Methylphenidate hydrochloride immediate release | 10 mg | 60 mg |
| Methylphenidate hydrochloride intermediate acting | 20 mg | 60 mg |
| Methylphenidate hydrochloride long acting | 18–36 mg | 72 mg |
| Methylphenidate hydrochloride oral solution | 10 mg | 60 mg |
| Methylphenidate hydrochloride chewable tablets | 10 mg | 60 mg |
| d,l-threo Methylphenidate slow release | 20 mg | 60 mg |
| Dexmethylphenidate (d-threo-methylphenidate) immediate release | 5 mg | 20 mg |
| Dexmethylphenidate (d-threo-methylphenidate) XR | 10 mg (adult) | 20 mg |
| Dextro-amphetamine immediate release | N/S | N/S |
| Dextro-amphetamine ER | 20 mg | N/S |
| Mixed amphetamine salts | N/S | N/S |
| Mixed amphetamine salts XR | 20 mg | N/S |
| Lisdexamfetamine | 30 mg | 70 mg |
| Atomoxetine | N/S | 100 mg |
| Clonidine immediate release | N/S | N/S |
| Clonidine extended release | 0.1 mg | 0.4 mg |
| Guanfacine immediate release | 0.5 mg | N/S |
| Guanfacine extended release | 1 mg | 7 mg |
| Bupropion IR | 100 mg two times a day | 100 mg tid |
| Buproprion SR | 150 mg qam | 150 mg two times a day |
| Bupropion XL | 150 mg qam | 300 mg qam |
| Modafinil | 200 mg | 400 mg |